Tenomodulin gene and obesity-related phenotypes

Annals of Medicine

Volumn 42, Issue 4, 2010, Pages 265-275

  Tolppanen, Anna Maija ^a   Kolehmainen, Marjukka ^a   Pulkkinen, Leena ^a   Uusitupa, Matti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Adipose tissue; Angiogenesis; Obesity; Tenomodulin

Indexed keywords

ANGIOPOIETIN 1; C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE PROTEIN; RANTES; TENOMODULIN; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADIPOSE TISSUE; ALZHEIMER DISEASE; ANGIOGENESIS; BODY SIZE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DISTRIBUTION; X CHROMOSOME;

ADIPOSE TISSUE; ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; OBESITY; PHENOTYPE; RNA, MESSENGER;

EID: 77952168149     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853891003801123     Document Type: Short Survey

References (75)

1. Trayhurn P, Wood IS. Adipokines: infl ammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92: 347-355 (Pubitemid 40277057) (Pubitemid 40277057)
2. Berg AH, Scherer PE. Adipose tissue, infl ammation, and cardiovascular disease. Circ Res. 2005;96:939-949 (Pubitemid 40712793) (Pubitemid 40712793)
3. Cao R, Brakenhielm E, Wahlestedt C, Thyberg J, Cao Y. Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci USA. 2001;98:6390-6395 (Pubitemid 32488247) (Pubitemid 32488247)
4. Smith U. Impaired (' diabetic') insulin signaling and action occur in fat cells long before glucose intolerance\is insulin resistance initiated in the adipose tissue? Int J Obes Relat Metab Disord. 2002;26:897-904. (Pubitemid 34756170) (Pubitemid 34756170)
5. Ledoux S, Queguiner I, Msika S, Calderari S, Rufat P, Gasc JM, et al. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes. 2008;57:3247-3257
6. Wang P, Mariman E, Renes J, Keijer J. The secretory function of adipocytes in the physiology of white adipose tissue. J Cell Physiol. 2008;216:3-13. (Pubitemid 351813090) (Pubitemid 351813090)
7. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007;115:1029-1038 (Pubitemid 46328297) (Pubitemid 46328297)
8. Haque WA, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002;87:2395.
9. Varma V, Yao-Borengasser A, Bodles AM, Rasouli N, Phanavanh B, Nolen GT, et al. Thrombospondin-1 is an adipokine associated with obesity, adipose infl ammation, and insulin resistance. Diabetes. 2008;57:432-439
10. Kloting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schon MR, et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2006;339:430-436 (Pubitemid 41697566) (Pubitemid 41697566)
11. Kolehmainen M, Salopuro T, Schwab US, Kekalainen J, Kallio P, Laaksonen DE, et al. Weight reduction modulates expression of genes involved in extracellular matrix and cell death: the GENOBIN study. Int J Obes (Lond). 2008;32: 292-303. (Pubitemid 351271783) (Pubitemid 351271783)
12. Dahlman I, Linder K, Arvidsson Nordstrom E, Andersson I, Liden J, Verdich C, et al. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr. 2005;81:1275-1285 (Pubitemid 41710227) (Pubitemid 41710227)
13. Saiki A, Olsson M, Jernas M, Gummesson A, McTernan PG, Andersson J, et al. Tenomodulin is highly expressed in adipose tissue, increased in obesity and down regulated during diet-induced weight loss. J Clin Endocrinol Metab. 2009; 94:3987-3994
14. Tolppanen AM, Pulkkinen L, Kolehmainen M, Schwab U, Lindstrom J, Tuomilehto J, et al. Tenomodulin is associated with obesity and diabetes risk: the Finnish diabetes prevention study. Obesity (Silver Spring). 2007;15:1082-1088 (Pubitemid 46932462) (Pubitemid 46932462)
15. Tolppanen AM, Pulkkinen L, Herder C, Koenig W, Koleh-mainen M, Lindstrom J, et al. The genetic variation of the tenomodulin gene (TNMD) is associated with serum levels of systemic immune mediators\the Finnish Diabetes Prevention Study. Genet Med. 2008;10:536-544
16. Tolppanen AM, Pulkkinen L, Kuulasmaa T, Kolehmainen M, Schwab U, Lindstrom J, et al. The genetic variation in the tenomodulin gene is associated with serum total and LDL cholesterol in a body size-dependent manner. Int J Obes (Lond). 2008;32:1868-1872
17. Tolppanen AM, Nevalainen T, Kolehmainen M, Seitsonen S, Immonen I, Uusitupa M, et al. Single nucleotide polymorphisms of the tenomodulin gene (TNMD) in age-related macular degeneration. Mol Vis. 2009;15:762-770
18. Tolppanen AM, Helisalmi S, Hiltunen M, Kolehmainen M, Schwab U, Pirttila T, et al. Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort. Neu-robiol Aging. 2009 Jun 11 (Epub ahead of print).
19. Cros N, Tkatchenko AV, Pisani DF, Leclerc L, Leger JJ, Marini JF, et al. Analysis of altered gene expression in rat soleus muscle atrophied by disuse. J Cell Biochem. 2001;83:508-519 (Pubitemid 33027494) (Pubitemid 33027494)
20. Yamana K, Wada H, Takahashi Y, Sato H, Kasahara Y, Kiyoki M. Molecular cloning and characterization of CHM1L, a novel membrane molecule similar to chondromodulin-I. Biochem Biophys Res Commun. 2001;280:1101-1106 (Pubitemid 32924453) (Pubitemid 32924453)
21. Shukunami C, Oshima Y, Hiraki Y. Molecular cloning of ten-omodulin, a novel chondromodulin-I related gene. Biochem Biophys Res Commun. 2001;280:1323-1327 (Pubitemid 32917788) (Pubitemid 32917788)
22. Brandau O, Meindl A, Fassler R, Aszodi A. A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Dev Dyn. 2001;221:72-80.
23. Shukunami C, Oshima Y, Hiraki Y. Chondromodulin-I and tenomodulin: a new class of tissue-specifi c angiogenesis inhibitors found in hypovascular connective tissues. Bio-chem Biophys Res Commun. 2005;333:299-307. (Pubitemid 40848292) (Pubitemid 40848292)
24. Sanchez-Pulido L, Devos D, Valencia A. BRICHOS: a conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem Sci. 2002;27: 329-332 (Pubitemid 34756511) (Pubitemid 34756511)
25. Docheva D, Hunziker EB, Fassler R, Brandau O. Tenom-odulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol. 2005;25:699-705. (Pubitemid 40096590) (Pubitemid 40096590)
26. Mulugeta S, Nguyen V, Russo SJ, Muniswamy M, Beers MF. A surfactant protein C precursor protein BRICHOS domain mutation causes endoplasmic reticulum stress, proteasome dysfunction, and caspase 3 activation. Am J Respir Cell Mol Biol. 2005;32:521-530 (Pubitemid 40770130) (Pubitemid 40770130)
27. Kimura N, Shukunami C, Hakuno D, Yoshioka M, Miura S, Docheva D, et al. Local tenomodulin absence, angiogenesis, and matrix metalloproteinase activation are associated with the rupture of the chordae tendineae cordis. Circulation. 2008;118:1737-1747
28. Hiraki Y, Tanaka H, Inoue H, Kondo J, Kamizono A, Suzuki F. Molecular cloning of a new class of cartilage-specifi c matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes. Biochem Biophys Res Commun. 1991;175:971-977
29. Hiraki Y, Inoue H, Iyama K, Kamizono A, Ochiai M, Shuku-nami C, et al. Identifi cation of chondromodulin I as a novel endothelial cell growth inhibitor. Purifi cation and its localization in the avascular zone of epiphyseal cartilage. J Biol Chem. 1997;272:32419-32426 (Pubitemid 28011925) (Pubitemid 28011925)
30. Oshima Y, Sato K, Tashiro F, Miyazaki J, Nishida K, Hiraki Y, et al. Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J Cell Sci. 2004;117(Pt 13):2731-2744 (Pubitemid 38997256) (Pubitemid 38997256)
31. Oshima Y, Shukunami C, Honda J, Nishida K, Tashiro F, Miyazaki J, et al. Expression and localization of tenomodu-lin, a transmembrane type chondromodulin-I-related angio-genesis inhibitor, in mouse eyes. Invest Ophthalmol Vis Sci. 2003;44:1814-1823
32. Mendias CL, Bakhurin KI, Faulkner JA. Tendons of myosta-tin-defi cient mice are small, brittle, and hypocellular. Proc Natl Acad Sci USA. 2008;105:388-393
33. Shukunami C, Takimoto A, Oro M, Hiraki Y. Scleraxis positively regulates the expression of tenomodulin, a differentiation marker of tenocytes. Dev Biol. 2006;298: 234-247
34. Hiraki Y, Shukunami C. Angiogenesis inhibitors localized in hypovascular mesenchymal tissues: chondromodulin-I and tenomodulin. Connect Tissue Res. 2005;46:3-11.
35. Shukunami C, Hiraki Y. Chondromodulin-I and tenomodu-lin: the negative control of angiogenesis in connective tissue. Curr Pharm Des. 2007;13:2101-2112
36. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, et al. Large-scale analysis of the human and mouse tran-scriptomes. Proc Natl Acad Sci USA. 2002;99:4465-4470
37. Schweitzer R, Chyung JH, Murtaugh LC, Brent AE, Rosen V, Olson EN, et al. Analysis of the tendon cell fate using. Scleraxis, a specifi c marker for tendons and ligaments. Development. 2001;128:3855-3866
38. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest. 2007;117:2362-2368
39. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387:83-90.
40. McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatin-defi cient mice. J Clin Invest. 2002;109: 595-601.
41. Kambadur R, Sharma M, Smith TP, Bass JJ. Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res. 1997;7:910-916
42. Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Com-mun. 2002;291:701-706
43. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004;350: 2682-2688
44. Feldman BJ, Streeper RS, Farese RV Jr, Yamamoto KR. Myostatin modulates adipogenesis to generate adipocytes with favorable metabolic effects. Proc Natl Acad Sci USA. 2006;103:15675-15680
45. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Atti-sano L. Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol. 2003;23:7230-7242
46. Milan G, Dalla Nora E, Pilon C, Pagano C, Granzotto M, Manco M, et al. Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab. 2004;89:2724-2727 (Pubitemid 38766356) (Pubitemid 38766356)
47. Comuzzie AG, Williams JT, Martin LJ, Blangero J. Searching for genes underlying normal variation in human adiposity. J Mol Med. 2001;79:57-70.
48. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mel-litus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350 (Pubitemid 32378388) (Pubitemid 32378388)
49. Eriksson J, Lindström J, Valle T, Aunola S, Hämälä inen H, Ilanne-Parikka P, et al. Prevention of type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia. 1999;42:793-801.
50. Wang J, Kuusisto J, Vanttinen M, Kuulasmaa T, Lindstrom J, Tuomilehto J, et al. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia. 2007;50:1192-1200
51. Gehrs KM, Anderson DH, Johnson LV, Hageman GS. Age-related macular degeneration\emerging pathogenetic and therapeutic concepts. Ann Med. 2006;38:450-471.
52. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-134
53. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: relative roles of genetic and environmental infl uences. Arch Ophthal-mol. 2005;123:321-327
54. Hyman L, Neborsky R. Risk factors for age-related macular degeneration: an update. Curr Opin Ophthalmol. 2002; 13:171-175
55. Buch H, Vinding T, la Cour M, Jensen GB, Prause JU, Nielsen N V. Risk factors for age-related maculopathy in a 14-year follow-up study: the Copenhagen City Eye Study. Acta Ophthalmol Scand. 2005;83:409-418 (Pubitemid 41086693) (Pubitemid 41086693)
56. van Leeuwen R, Ikram MK, Vingerling JR, Witteman JC, Hofman A, de Jong P T. Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci. 2003;44:3771-3777
57. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, Tamarat R, et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004;109:656-663
58. Silverman KJ, Lund DP, Zetter BR, Lainey LL, Shahood JA, Freiman DG, et al. Angiogenic activity of adipose tissue. Biochem Biophys Res Commun. 1988;153:347-352
59. Bouloumie A, Lolmede K, Sengenes C, Galitzky J, Lafontan M. Angiogenesis in adipose tissue. Ann Endocrinol (Paris). 2002;63(2 Pt 1):91-95
60. Larson DR, Zipfel WR, Williams RM, Clark SW, Bruchez MP, Wise FW, et al. Water-soluble quantum dots for multiphoton fl uorescence imaging in vivo. Science. 2003;300:1434-1436
61. Fukumura D, Ushiyama A, Duda DG, Xu L, Tam J, Krishna V, et al. Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res. 2003; 93:e88-97.
62. Voros G, Maquoi E, Demeulemeester D, Clerx N, Collen D, Lijnen HR. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology. 2005;146:4545-4554
63. Crandall DL, Goldstein BM, Lizzo FH, Gabel RA, Cervoni P. Hemodynamics of obesity: infl uence of pattern of adipose tissue cellularity. Am J Physiol. 1986;251(2 Pt 2):R314-9.
64. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat Med. 2004;10:625-632
65. Rupnick MA, Panigrahy D, Zhang CY, Dallabrida SM, Lowell BB, Langer R, et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA. 2002; 99:10730-10735
66. Brakenhielm E, Cao R, Gao B, Angelin B, Cannon B, Parini P, et al. Angiogenesis inhibitor, TNP-470, prevents diet-induced and genetic obesity in mice. Circ Res. 2004;94:1579-1588
67. Kampf C, Bodin B, Kallskog O, Carlsson C, Jansson L. Marked increase in white adipose tissue blood perfusion in the type 2 diabetic GK rat. Diabetes. 2005;54:2620-2627
68. Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T. Altered morphology and 3D architecture of brain vascula-ture in a mouse model for Alzheimer's disease. Proc Natl Acad Sci USA. 2008;105:3587-3592
69. Thirumangalakudi L, Samany PG, Owoso A, Wiskar B, Grammas P. Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease. J Alzheimers Dis. 2006;10:111-118
70. Das SK, Chu WS, Mondal AK, Sharma NK, Kern PA, Rasouli N, et al. Effect of pioglitazone treatment on endo-plasmic reticulum stress response in human adipose and in palmitate-induced stress in human liver and adipose cell lines. Am J Physiol Endocrinol Metab. 2008;295:E393-400.
71. Boden G, Duan X, Homko C, Molina EJ, Song W, Perez O, et al. Increase in endoplasmic reticulum stress-related proteins and genes in adipose tissue of obese, insulin-resistant individuals. Diabetes. 2008;57:2438-2444
72. Ozawa K, Tsukamoto Y, Hori O, Kitao Y, Yanagi H, Stern DM, et al. Regulation of tumor angiogenesis by oxygen-regulated protein 150, an inducible endoplasmic reticulum chaperone. Cancer Res. 2001;61:4206-4213
73. Abcouwer SF, Marjon PL, Loper RK, Vander Jagt DL. Response of VEGF expression to amino acid deprivation and inducers of endoplasmic reticulum stress. Invest Ophthalmol Vis Sci. 2002;43:2791-2798
74. Manley PN, Ancsin JB, Kisilevsky R. Rapid recycling of cholesterol: the joint biologic role of C-reactive protein and serum amyloid A. Med Hypotheses. 2006;66:784-792
75. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. 2008;9:367-377